Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas
Clinical trial NCT03042819 · COMPLETED
Trial details
- NCT number
- NCT03042819
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-16
- Primary completion
- 2019-11-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.